Exercise‐induced ventricular tachycardia in a case with hypertrophic cardiomyopathy taking cibenzoline
| Autor: | Mihoko Kawabata, Kenzo Hirao, Masahiko Goya, Tetsuo Sasano, Shinya Shiohira, Shingo Maeda |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
QRS duration sodium channel blocker use‐dependent Case Report macromolecular substances Case Reports 030204 cardiovascular system & hematology Ventricular tachycardia 03 medical and health sciences chemistry.chemical_compound QRS complex 0302 clinical medicine Sodium channel blocker Physiology (medical) Internal medicine Heart rate medicine 030212 general & internal medicine cardiovascular diseases proarrhythmia Proarrhythmia business.industry Hypertrophic cardiomyopathy General Medicine medicine.disease hypertrophic cardiomyopathy chemistry Cibenzoline Ventricular fibrillation Cardiology cardiovascular system ventricular tachycardia Cardiology and Cardiovascular Medicine business |
| Zdroj: | Annals of Noninvasive Electrocardiology |
| ISSN: | 1542-474X 1082-720X |
| Popis: | We report a 17‐year‐old woman with hypertrophic cardiomyopathy (HCM) successfully resuscitated from ventricular fibrillation while taking cibenzoline. During exercise–stress testing before implanting an implantable cardioverter–defibrillator, ventricular tachycardia was induced and thought to be a proarrhythmia due to the use‐dependent effect of the Na channel blockade with cibenzoline. In patients with arrhythmogenic substrates such as HCM, it is critical to pay attention to the proarrhythmic effects of class I antiarrhythmic drugs while increasing heart rate. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text